Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/1998
03/26/1998WO1998011896A1 Combination therapy for reducing the risks associated with cardiovascular disease
03/26/1998WO1998011779A1 Delivery of therapeutic gene products by intestinal cell expression
03/26/1998WO1998006400A3 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
03/26/1998WO1998001159A3 Composition for enhanced uptake of polar drugs from mucosal surfaces
03/26/1998DE19704301C1 Human endoglin gene promoter
03/26/1998CA2267343A1 Strain selection of pneumococcal surface proteins
03/26/1998CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/26/1998CA2266447A1 Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient
03/26/1998CA2266341A1 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998CA2266339A1 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/26/1998CA2265827A1 Combination therapy for reducing the risks associated with cardiovascular disease
03/26/1998CA2264744A1 Delivery of therapeutic gene products by intestinal cell expression
03/26/1998CA2215856A1 Dihydrobenzofluorene compounds, intermediates, compositions, and methods
03/26/1998CA2214931A1 Tetrahydrobenzo-a-fluorene compounds and method of use
03/26/1998CA2214929A1 Naphthofluorene compounds, intermediates, compositions and methods
03/25/1998EP0831089A1 Benzothiophene compounds, intermediates, processes, compositions, and methods
03/25/1998EP0830455A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
03/25/1998EP0830390A1 Hydrophobic heteroatom-containing sequestrant for cholesterol depletion
03/25/1998EP0830374A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
03/25/1998EP0830372A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
03/25/1998EP0830350A1 Novel n-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1h-benzo[b][1,4]diazepin-3-yl)-acetamides
03/25/1998EP0830348A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
03/25/1998EP0830346A1 2-substituted benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
03/25/1998EP0830345A1 Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
03/25/1998EP0830344A1 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors
03/25/1998EP0830343A1 Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
03/25/1998EP0830143A1 Use of leukemia inhibitory factor and endothelin antagonists
03/25/1998EP0830130A1 Tnf-alpha converting enzyme
03/25/1998CN1177356A Bicyclic benzazepine derivatives as vasopressin antagonists
03/25/1998CN1177351A Hydroxylamine derivatives useful for enhancing molecular chaperon prodn. and the prepn. thereof
03/25/1998CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine
03/25/1998CN1177294A Water based topical cream contg. nitroglycerin, prepn. method therefor and use thereof
03/25/1998CN1176965A Novel pyrimido £1, 2 -alpha| indoles
03/25/1998CN1176820A Red ginseng and hawthorn fruit health-care wine
03/25/1998CN1176808A Capsule traditional Chinese patent medicine
03/25/1998CN1176786A (5-androstene -17 -one -3 beta hydroxyl) diacid ester, and it pharmaceutical use
03/25/1998CN1037840C Diphenylmethyl piperazine derivatives
03/24/1998US5731455 Alkyl 2-alkylacylacrylate chemical intermediate; anticholesterol agents
03/24/1998US5731441 Hydroxamic acid derivatives with tricyclic substitution
03/24/1998US5731432 Inhibitors of adenosine monophosphate deaminase
03/24/1998US5731351 Antiarrhythmia agents
03/24/1998US5731350 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
03/24/1998US5731345 Seco-D steroids active on the cardiovascular system and pharmaceutical compositions containing same
03/24/1998US5731335 Nervous system disorders; stroke; antiischemic agents; cognition activators
03/24/1998US5731333 Learning and memory enhancement, antidepressants
03/24/1998US5731332 Leukotriene antagonists; antiinflammatory agents, antiallergens
03/24/1998US5731331 Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles
03/24/1998US5731328 Administering 2-phenyl-3-aroylbenzothiophene compounds to a patient
03/24/1998US5731326 Platelet derived growth factor
03/24/1998US5731324 Glycoprotein IIb/IIIa antagonists
03/24/1998US5731323 Quinuclidine derivatives as squalene synthase inhibitors
03/24/1998US5731322 Octahydro-1H-pyrrolo 3,2-g!and 2,3-g!isoquinoline derivatives
03/24/1998US5731321 Endothelin receptor antagonists
03/24/1998US5731315 Inhibitors of factor xa
03/24/1998US5731309 Asthma
03/24/1998US5731306 Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo c!azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
03/24/1998US5731294 Inhibition of neovasularization using VEGF-specific oligonucleotides
03/24/1998US5731286 Cyclic neurokinin A antagonists
03/24/1998CA2214919A1 Benzothiophene compounds, intermediates, processes, compositions, and methods
03/24/1998CA1339777C Superoxide dismutase polymers
03/20/1998CA2185950A1 Process for preparing intermediates for thrombin inhibitors
03/19/1998WO1998011236A1 Aspartic protease
03/19/1998WO1998011223A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998WO1998011212A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998WO1998011206A2 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
03/19/1998WO1998011140A1 A process for purifying apolipoproteins and a composition for use in the process
03/19/1998WO1998011129A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
03/19/1998WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production
03/19/1998WO1998011119A1 Novel pyranoside derivatives
03/19/1998WO1998011089A1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors
03/19/1998WO1998011066A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
03/19/1998WO1998011062A1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
03/19/1998WO1998011049A1 Lipoxin compounds and their use in treating cell proliferative disorders
03/19/1998WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998WO1998010652A1 NOVEL trpS
03/19/1998WO1998010650A1 Method of treating endothelial injury
03/19/1998DE19637123A1 Neue Pyranosidderivate New Pyranosidderivate
03/19/1998CA2277199A1 A process for purifying apolipoproteins and a composition for use in the process
03/19/1998CA2265928A1 C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
03/19/1998CA2265927A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998CA2265877A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
03/19/1998CA2265467A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998CA2262818A1 Modified amino acids, pharmaceuticals containing these compounds and methods for their production
03/18/1998EP0829480A2 Tetrazolyl-substituted quinuclidines as substance P antagonists
03/18/1998EP0828849A1 High-affinity oligonucleotide ligands to growth factors
03/18/1998EP0828833A1 Chemokine n-terminal deletion mutations
03/18/1998EP0828831A2 A novel human purinergic p 2u? receptor
03/18/1998EP0828746A1 Novel quinoxaline dione derivatives, their production and their use in medicaments
03/18/1998EP0828737A1 Isoxazoline and isoxazole derivatives as integrin receptor antagonists
03/18/1998EP0828732A1 Peptidyl compounds and their therapeutic use
03/18/1998EP0828492A1 Method for preventing intervention-associated stenosis following non-bypass, invasive interventions
03/18/1998EP0828491A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects
03/18/1998EP0828490A1 RAR-beta SELECTIVE RETINOID COMPOUNDS FOR INHIBITING GENE EXPRESSION PROMOTED BY AP1 PROTEIN AND THEIR USE IN THERAPY
03/18/1998EP0828488A1 Isothiazolones
03/18/1998EP0828485A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
03/18/1998EP0674638B1 Substituted triols
03/18/1998EP0619734B1 New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole
03/18/1998EP0598753B1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
1 ... 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 ... 1595